We reported in this manuscript that TGF-β1 induces apoptosis in AML12 murine hepatocytes, which is associated with the activation of p38 MAPK signaling pathway. SB202190, a specific inhibitor of p38 MAPK, strongly inhibited the TGF-β1-induced apoptosis and PAI-1 promoter activity. Treatment of cells with TGF-β1 activates p38. Furthermore, over-expression of dominant negative mutant p38 also reduced the TGF-β1-induced apoptosis. The data indicate that the activation of p38 is involved in TGF-β1-mediated gene expression and apoptosis.
INTRODUCT ION
Apoptosis is a fundamental important biological process that is required to maintain the integrity and homeostasis of multicellular organism [1] . It seems that apoptosis is a predominant type of active cell death in the liver. Endogenous factors, such as transforming growth factor β1 (TGF-β1), activin A, CD95 ligand, and tumor necrosis factor (TNF) may be involved in induction of apoptosis in the liver [2] .
Transforming growth factor β(TGF-β) is a member of a super-family of multifunctional cytokines that regulate cell proliferation, differentiation, and apoptosis. Investigating the signaling pathways induced by TGF-β is important for the understanding of the mechanism that underlies the various biological events mediated by TGF-β. It was demonstrated that increased PLD activity are involved in TGF-β-induced growth inhibition of several types of epithelial cell lines [3] . TGF-β can induce apoptosis in normal hepatocytes [4] [5] [6] [7] and hepatoma cells [8] , [9] . It has been found that TGF-β-induced apoptosis is associated with the generation of reactive oxygen species (ROS) [10] , [11] . Anti-oxidants, such as vitamin C, can block the TGF-β-induced apoptotic process [12] . Recently, several reports provide evidence showing that TGF-β-induced apoptosis can be mediated by caspases [5] , [9] , [13] , [14] . It has also been reported that TGF-β induces apoptosis through the regulation of the expression of pro-and anti-apoptotic molecules, such as p53, Bax, Bik, Bcl-2, and Bcl-XL [6] , [14] , [15] .
TGF-β exerts its action through binding with type I and type II serine/threonine kinase receptors. The signaling events downstream of these receptor complexes are mediated by Smad family. Following phosphorylation by the type I receptor, Smad2 or Smad3 forms a heteromeric complex with Smad4. The complex formed then translocates to the nucleus where it can directly or indirectly regulate gene transcription [16] [17] [18] [19] . In addition to the Smad pathway, another signaling pathway of TGF-β involves the TGF-β activated kinase 1(TAK1), which was identified as a member of MAP kinase family [20] . It has been known that TAK1 kinase can acitvate p38 mitogen-activated protein kinase (p38 MAPK) and c-Jun Nterminal kinase (JNK) [21] [22] [23] .
p38 and JNK are members of MAP kinase superfamily, which have been implicated in the re-sponses to stress and inflammation. Although p38 and JNK mediate a wide range of biological effects, the activations of p38 and JNK by some stimuli result in apoptosis [24] [25] [26] [27] [28] . However, the signaling mechanism of TGF-β-induced apoptosis remains poorly understood. Since p38 and JNK are often activated by TGF-β and TGF-β-induced gene expression can be mediated by p38 and JNK [21] [22] [23] , [29] , [30] , it is likely that p38 and JNK are involved in TGF-β-induced apoptosis. To investigate this possibility, we studied the involvement of p38 and JNK signaling components in TGF-β-induced apoptosis in AML12 murine hepatocytes.
MATERIALS AND METHODS

Materials
Cell culture reagents and fetal bovine serum (FCS) were purchased from GIBCO. The polyclonal antibodies against p38 and JNK and the monoclonal antibodies against phosphorylated p38 MAPK and phosphorylated JNK were bought from Santa Cruz (USA). LipofectAMINE was purchased from GIBCO BRL (USA). Dual luciferase assay system was purchased from Promega (USA).
Methods
Cell culture
AML-12 murine heptocytes (American Tissue Culture Collection, ATCC CRL-2254) were cultured in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham s F12 medium containing insulin (5 μg/ml), transferrin (5 μg/ml), selenium (5 μg/ml), dexamethasone (40 ng/ml), and 10% fetal bovine serum. Cell cultures were maintained at 37 o C in a humidified atmosphere of 5% CO 2 .
Assessment of apoptosis
Morphological evaluation was performed as described [31] . Briefly, medium was gently removed after treatment to prevent detachment of cells. Cells were stained by acridine orange (2 μg/ ml) and ethidium bromide (2 μg/ml) in PBS. Fluorescence was visualized immediately with a fluorescent microscope. The normal cells appear uniformly green. Early apoptotic cells can be stained green and contain bright green dots in the nuclei as a consequence of chromatin condensation and nuclear fragmentation. Late apoptotic cells will be incorporated by ethidium bromide and therefore stained orange with condensed and often fragmented nuclei.
DNA fragmentation of apoptotic cells was detected as described by Lindenboim et al [32] with minor modifications. The cells were rinsed with PBS twice and lysed on ice for 30 min in 10 mM Tris-Cl pH 8.0, 25 mM EDTA pH 8.0, and 0.25% Triton X-100. After centrifugation at 13,800 g for 15 min, the supernatant was incubated with RNase at 37 o C for 60 min and then with proteinase K at 56 o C overnight. The contents were extracted sequentially with phenol, phenol:chloroform(1:1) and chloroform. The DNAs in aqueous phase were precipitated and analyzed by 1.5% agarose gel electrophoresis. Gel was visualized and photographed under transmitted UV light.
Preparation of cell lysates and immunoblotting
Cells were lysed in 10 mM Tris pH 7.4, 1 mM EDTA, 0.5 mM EGTA, 150 mM NaCl, 1% Triton X-100, 50 mM NaF, 10 mM Na 4 P 2 O 7 .10H 2 O, 5 μg/ml aprotinin, 5 μg/ml leupeptin and 1 mM PMSF. Fifty microgram of proteins were electrophoresed in SDSpolyacrylamide gel and transferred onto nitrocellulose membranes (Hybond TM ECL TM ). The membranes were blocked with 5% skim milk in Tris-buffered saline (TBS) containing 0.1% Tween-20 (TBS-T) and subsequently incubated with antibodies. After washed with TBS-T, the membranes were incubated with horseradish peroxidase (HRP)-conjugated antibody. Immunoreactive bands were detected with enhanced chemiluminescent reagents (Amersham).
Transfections and luciferase reporter assays
Plasmids were introduced into AML12 cells with LipofectAMINE. The expressions of p38 and p38AF were identified with immunoblotting. p3TP-Lux plasmid, which contains a luciferase expression unit under the control of PAI-1 promoter, was introduced into AML12 cells together with pRL-SV40. Sixteen hours after transfection, the cells were treated with TGF-1 (10 ng/ml) in culture medium containing 0.25% FCS. After 16 h, the cells were lysed and the luciferase activity was measured with dual luciferase assay system. The luciferase activity was normalized to pRL-SV40 luciferase activity to account for transfection efficiency and cell viability.
RESULTS
SB202190 inhibits the TGF-β1-induced apoptosis in AML12 hepatocytes
To test the possible involvement of p38 signaling pathway in TGF-β1-induced apoptosis, we first investigated the role of SB202190, a selective inhibitor of p38, on the TGF-β1-induced apoptosis in AML12 cells. Treatment of AML12 cells with TGFb1 for 24 h resulted in an apoptotic response of cells as detected by the observation of cell morphology and by the appearance of apoptotic nuclei. Pretreatment of cells with SB202190 (10 μM) blocked these apoptotic response induced by TGF-β1 ( Fig  1A) . Same results were obtained by DNA fragmentation assay. As shown in Fig 1B, TGF-1-induced DNA fragmentation was also completely inhibited by SB202190.
Effect of SB202190 on TGF-β1-induced PAI-1 transcription activity
To determine whether p38 has any effect on TGF-β1-induced gene expression, we performed the Luciferase reporter assays. As shown in Fig 2, TGF-β1 induced 7.3-fold increase in luciferase activity. Treatment of cells with SB202190 alone did not affect luciferase activity. However, in the presence of p38, TGF-β1-induced luciferase activity in AML12 cells was reduced to 3.0 fold, suggesting a role of p38 in modulating the TGF-β1-induced gene expression. 
TGF-β1 activates p38 MAPK
To further investigate the involvement of p38 in TGF-β1-induced apoptosis, we determined the activation of p38 MAPK in response to TGF-β1 treatment by measuring the phosphorylation of p38 with phospho-specific antibody. As shown in Fig 3A , treatment of cells with TGF-1 induced a rapid activation of p38 MAPK, which peaked at 30 min and lasted for at least 2 h, and pretreatment of SB202190 could also inhibit the p38 MAPK activation by TGF-β1. No activation of JNK by TGF-b1 was detected during the 4 h s treatment (Fig 3B) . The results indicate that p38 MAPK but not JNK was activated in TGF-β1-induced cell apoptosis.
Dominant negative mutant p38 reduces TGF-β1-induced apoptosis in AML12 cells
To investigate the role of p38 signaling pathway in TGF-β1-induced apoptosis, wild type and dominant negative mutant p38 (p38AF) were introduced into AML12 cells. The vector pcDNA3 was also transfected into AML12 cells as a control. After screened with G418, the expression of Flag-tagged p38 and p38AF were detected with immunoblotting ( Fig 4A) . The percentage of apoptotic cells was determined with acridine orange/ethidium staining and fluorescent microscopy. Fig 4B demonstrated that dominant negative mutant p38 significantly inhibited TGF-β1-induced apoptosis, suggesting that p38 MAPK plays a role in TGF-β1-induced apoptosis.
DISSCUSSION
It was reported that TGF-β-induced apoptosis is associated with up-regulation of pro-apoptotic molecules such as Bax and p53 and/or with downregulation of anti-apoptotic molecules such as Bcl-2 and Bcl-X L [6] , [14] , [15] . TGF-b-induced apoptosis in AML-12 cells can be blocked by the inhibition of protein synthesis [33] . Although the signaling pathways of TGF-β-mediated many physiological functions have been well described, the signaling mechanisms by which TGF-β induce cell apoptosis are not well understood.
TGF-β can activate two independent signaling pathways, TAK1-and Smad-mediated pathways, which often interact in the regulation of TGF-β1 signaling. It has been reported that Smad3 phosphorylation by JNK facilitates both its activation by the TGF-β receptor complex and its nuclear accumulation [34] . It was shown that Smad signaling pathway plays a role in TGF-β-induced apoptosis. The overexpression of DPC4/Smad4 in MDCK cells is sufficient to induce the activation of gene transcription, cell cycle arrest, and apoptosis [35] . It has also been shown that constitutive expression of Smad3 did not induce apoptosis, but made human normal epithelial cells more sensitive to TGF-β-induced apoptosis [36] .
JNK and p38 MAPK have been shown to mediate apoptosis induced by many stimuli [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . Though it has been shown that TGF-β activates JNK and p38 signaling molecules [21] [22] [23] , their implication in TGF-β-induced apoptosis is not clear. The fact that TGF-β1 induces activation of p38 in AML12 cells suggests that p38 MAPK is probably involved in the TGF-1-induced apoptosis. The results indicate that p38 signaling pathway was activated in TGF-β1-induced apoptosis in AML12 cells. SB202190, an selective inhibitor of p38, completely inhibited TGF-β1-induced apoptosis in AML 12 cells. Transfection of a dominant negative mutant of p38 into AML12 cells also significantly reduced the TGF-b1-induced apoptosis. Both specific inhibitor and dominant negative mutant could interfere TGF-β-induced apoptosis. The data further indicate that p38 signaling pathway plays a role in TGF-β1-induced apoptosis.
